<DOC>
	<DOCNO>NCT02370303</DOCNO>
	<brief_summary>The purpose study isolate measure circulate tumor cell blood stream advance detection cancer treatment monitoring . In study , investigator utilize novel technology circulate tumor cell detection order evaluate presence patient lung cancer .</brief_summary>
	<brief_title>A Study Isolate Test Circulating Tumor Cells Using ClearCellÂ® FX EP+ System</brief_title>
	<detailed_description>The plan collect blood tumor sample patient 's lung cancer order validate technology detect circulate tumor cell . The investigator also obtain postoperative blood sample see decrease overall circulate tumor cell measurement tumor surgically remove .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>Stage IB nonsmall cell lung cancer metastatic lung cancer Age &gt; 18 year old Willing able consent study No prior history neoadjuvant therapy . Age &lt; 18 year old Unable provide consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>